Graft Polymer (UK) PLC Director Share Purchase (6117Z)
May 16 2023 - 8:08AM
UK Regulatory
TIDMGPL
RNS Number : 6117Z
Graft Polymer (UK) PLC
16 May 2023
16 May 2023
Graft Polymer (UK) Plc
("Graft Polymer", the "Company", and together with its
subsidiaries, the "Group")
Director Share Purchase
Graft Polymer (UK) Plc, a business focused on the development
and commercial production of modified polymer solutions including
additives, alloys, synthesis, and drug delivery systems , announces
that on 15 May 2023, Alex Brooks, Non-Executive Director of Graft
Polymer, acquired 56,399 Ordinary Shares at an average price of 4.6
pence per Ordinary Share. Following this acquisition of shares,
Alex Brooks has a total beneficial interest in 475,004 Ordinary
Shares, representing approximately 0.46% of the total issued share
capital of the Company.
-Ends-
Authorised for release by the board of directors, for further
information please contact:
Graft Polymer (UK) Plc (via St Brides Partners (Public
St Brides Partners) Relations)
Roby Zomer, Non Executive Chairman Catherine Leftley
Yifat Steuer, CFO and Executive Ana Ribeiro
Director Max Bennett
https://www.graftpolymer.com graftpolymer@stbridespartners.co.uk
Turner Pope Investments (Broker)
James Pope
Andy Thacker
+44 20 3657 0050
About Graft Polymer
Graft Polymer is a London Stock Exchange listed company (GPL.L)
with a cutting-edge, cash-flow positive, research and development
(R&D) and manufacturing facility based in Slovenia which has
already introduced more than 50 products to the market. The core
business of the Group comprises polymer modification and drug
delivery system developments. The Group has developed a proprietary
set of polymer modification technologies which uses recycled raw
materials and a closed loop system to reduce waste. Graft Polymer's
technology can improve existing products and processing
methodologies by enhancing performance, simplifying manufacturing,
reducing material consumption, widening the choice of feedstocks,
and reducing costs.
Graft Polymer has two divisions: the first division focusses on
polymer modification; the second is GraftBio which develops IP for
Bio/Pharma applications (including a drug delivery system to
support and provide solutions to the market, which had been heavily
impacted by the COVID-19 pandemic). A significant milestone was
reached in May 2022 when the Slovenian manufacturing facility was
granted a Hazard Analysis and Critical Control Point (HACCP)
Certificate.
Environment, Social and Governance is at the forefront of the
Group's strategy and the facility in Slovenia has been granted ISO
14001 accreditation in recognition of the environmental management
systems in place to reduce waste. Graft Polymer only uses REACH and
ROHS certificated raw materials instead of toxic raw materials, and
its extensive R&D programme has also developed specialised
recycling polymer additives which increases the strength of
recycled blends and plastic products whilst also reducing plastic
waste by between 40 and 50 per cent.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Alex Brooks
--------------------------------------- ---------------------------------------------
Reason for the notification
2
--------------------------------------------------------------------------------------
a) Position/status Non-Executive Director of Graft Polymer
(UK) Plc
--------------------------------------- ---------------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- ---------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Graft Polymer (UK) Plc
--------------------------------------- ---------------------------------------------
b) LEI 2138005PH7OJRCRPUD88
--------------------------------------- ---------------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------------
a) Description of the Ordinary Shares
financial instrument,
type of instrument
Identification code GB00BMD1Z199
b) Nature of the transaction On market purchase of shares
--------------------------------------- ---------------------------------------------
c) Price(s) and volume(s)
-------------------- --------------------
Price(s) Volume(s)
-------------------- --------------------
4.6p 56,399
-------------------- --------------------
d) Aggregated information
N/A Single Transaction
- Aggregated volume
- Price
e) Date of the transaction 15 May 2023
--------------------------------------- ---------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------------- ---------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHSFFFDMEDSESI
(END) Dow Jones Newswires
May 16, 2023 09:08 ET (13:08 GMT)
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Apr 2024 to May 2024
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From May 2023 to May 2024